The New York Times – Gilead will donate Truvada to U.S. for H.I.V. prevention

The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.

Associated Press – Juul’s ‘switch’ campaign for smokers draws new scrutiny

The young models and the candy-colored graphics that helped propel Juul to the top of the e-cigarette market are gone. In their place are people like Carolyn, a 54-year-old former smoker featured in new TV commercials touting Juul as an alternative for middle-age smokers.

CBS News – What would the world look like #WithoutMom? Emotional campaign raises awareness of “epidemic” killing moms

A new social media campaign is encouraging people to share what they would not have been able to achieve #WithoutMom and vow to fight to never have to imagine a world without her.

Science Alert – Report: These 25 US places are at the highest risk of an imminent measles outbreak

We’re not even halfway through 2019, and already the US has confirmed more than 700 cases of measles. Thanks to a mix of factors – not least, non-medical exemptions from vaccination – some areas are at higher risk than others.

Kaiser Health News – State bans pesticide linked to developmental problems

California will ban the use of a widely used pesticide in the face of “mounting evidence” that it causes developmental problems in children, state officials announced Wednesday.